{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-032567","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.452399+00:00","generated_at":"2026-06-19T18:10:28.030828+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"AVITA Medical to report Q4/FY2022 results on Feb 23, 2023, provide 2023 guidance","bullets":["Results due after market close on Thursday, Feb 23, 2023.","Conference call at 1:30 p.m. PT (Feb 23) / 8:30 a.m. AEDT (Feb 24).","Webcast available on ir.avitamedical.com; replay afterward.","2023 revenue guidance will be discussed on the call."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-032567","json":"https://secwatch.observer/filing/0001193125-23-032567.json","markdown":"https://secwatch.observer/filing/0001193125-23-032567.md","text":"https://secwatch.observer/filing/0001193125-23-032567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000119312523032567/0001193125-23-032567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000119312523032567/d410703d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T18:10:28.030828+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}